Showing results (281-290 of 574) with videos related to
Sort By:
Pageof 58
Reviews of Infectious Diseases|May 1, 1985
Bacteremia caused by Aeromonas species in hospitalized cancer patientsR L Harris, V Fainstein, L Elting, et al.The American Journal of Medicine|November 29, 1985
Ticarcillin plus clavulanic acid in the treatment of patients with cancerV Fainstein, L Elting, S Pitlik, et al.The Journal of Antimicrobial Chemotherapy|January 1, 1985
Cefotaxime: single agent therapy for infections in cancer patients with adequate granulocyte countsK Rolston, R Bolivar, V Fainstein, et al.Cancer Treatment Reports|June 1, 1985
Phase I-II clinical trial of thymidine, 5-FU, and PALA given in combinationD F Chiuten, M Valdivieso, A Bedikian, et al.Infection Control and Hospital Epidemiology|April 1, 1992
Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremiaI Raad, S Davis, A Khan, et al.Antimicrobial Agents and Chemotherapy|April 1, 1994
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolonesN Dholakia, K V Rolston, D H Ho, et al.The Journal of Infectious Diseases|August 1, 1993
Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placementI Raad, W Costerton, U Sabharwal, et al.Cancer|May 15, 1981
Protected environment - prophylactic antibiotic program for malignant sarcomas: randomized trial during remission induction chemotherapyG P Bodey, V Rodriguez, W K Murphy, et al.Journal of Clinical Microbiology|July 1, 1982
Diagnostic value of the enzyme-linked immunosorbent assay for detection of Candida albicans cytoplasmic antigen in sera of cancer patientsG F Araj, R L Hopfer, S Chesnut, et al.The Journal of Antimicrobial Chemotherapy|October 1, 1987
In-vitro activity of LY146032 against gram-positive isolates from cancer patientsH Saito, K V Rolston, D H Ho, et al.Pageof 58